A device to help fuse vertebrae in the lower spine in order to treat degenerative disc disease.
It differs from other, similar devices in that it uses genetically engineered protein to help build bone tissue in the fusion process, instead of using a graft of the patient's own bone (an autograft).
The fusion cage component maintains the spacing and temporarily stabilizes the diseased region of the spine, while the InFUSE Bone Graft component is used to form bone which would permanently stabilize (fuse) this portion of the spine.
The device is used in the lower region of the spine (L4-S1) to treat degenerative disc disease.
A clinical study showed that the use of this device was as safe and effective in promoting spinal fusion as the same fusion cage component filled with autograft bone.
This device should not be used for patients:
In addition, it is not known if a woman who becomes pregnant after receiving the device could have a second immune reaction to the BMP-2 normally found in a developing fetus, which might harm either mother or fetus.